Appointments • Support Our Research

Arthritis Information

Support Research at the Johns Hopkins Arthritis Center

  • Disease Information
    • Rheumatoid Arthritis
    • Psoriatic Arthritis
    • Ankylosing Spondylitis
    • Osteoarthritis
    • Gout
    • Lyme Disease
    • Osteoporosis
  • Patient Corner
    • Arthritis Drug Information Sheets
    • Managing Your Arthritis
    • Educational Videos for Patients
  • Ask The Expert
  • Physician Corner
    • Rheumatology Conference
  • Our Research
    • Patient-Centered Outcomes Research
    • Research Studies
    •  The Camille Julia Morgan Arthritis Research and Education Fund
  • About Us
    • Appointment Information
    • Contact Us
    • Our Faculty
    • Our Staff
    • Rheumatology Specialty Centers
You are here: Home / Archives for Jon Giles, MD

Study Demonstrates Promise for Spleen Tyrosine Kinase (Syk) Inhibitors for the Treatment of Rheumatoid Arthritis

September 24, 2010 By Jon Giles, MD

Spleen tyrosine kinase (Syk) is an important mediator of inflammatory signals from extracellular receptors to the nucleus of immune cells.  Inhibiting Syk with the oral, small-molecule inhibitor fostamatinib has shown efficacy compared to placebo in a short term study of RA patients on background methotrexate.  Here, Weinblatt et al (NEJM 2010; published online ahead of […]

Lower Dose of Rituximab for RA Treatment Explored

September 18, 2010 By Jon Giles, MD

The dosage of rituximab commonly used in clinical practice (1000 mg infused twice, separated by two weeks) is largely empirically based.  It is unclear whether lower doses will result in reduced efficacy or improved safety.  Here, Emery et al (Ann Rheum Dis 2010; 69: 1629) explore patient outcomes in RA patients treated with 2 x […]

Urate Lowering Effects of Milk Explored

August 27, 2010 By Jon Giles, MD

Ingestion of dairy products has been associated with a lower risk of gout in observational studies. However, the mechanism underlying this protective effect is unstudied. In addition, the association could be related more to health behaviors associated with milk drinking, such as better general health and less consumption of alcohol and red meat, rather than […]

Are TNF Inhibitors Efficacious for the Treatment of Sciatica?

August 18, 2010 By Jon Giles, MD

Inflammatory cytokines are implicated in the painful symptoms of sciatica, a common form of lumbar radiculopathy associated with intense pain and dysfunction. Case reports have suggested that TNF inhibitors may improve pain in individuals with sciatica. However, since sciatica is often self-limited, uncontrolled reports of efficacy may be misleading. Here, Genevay et al (Arthritis Rheum […]

Does Antioxidant Intake Protect Against the Development of Rheumatoid Arthritis or Lupus?

August 3, 2010 By Jon Giles, MD

Antioxidants may protect tissues against damage, reduce systemic inflammation, and modulate antigen presentation by inflammatory cells.  However, no large-scale investigation on whether dietary and/or supplement intake of antioxidants is protective against the development of autoimmune rheumatic disease.  Here, Costenbader et al (American Journal of Epidemiology 2010; 172(2): 205) explore antioxidant intake and the risk of […]

Are the Incidence and Prevalence of RA Changing in the United States?

July 5, 2010 By Jon Giles, MD

The epidemiology of rheumatoid arthritis (RA) is influenced by a number of factors, including survival, changes in diagnostic tools, and temporal trends in environmental factors that may promote or protect from disease.  Here, Myasoedova et al (Arthritis Rheum 2010; 62(6): 1576) explore the trends in RA incidence and prevalence over 50 years in a population-based […]

Denosumab Receives Approval Recommendation for the Treatment of Post-Menopausal Osteoporosis

June 22, 2010 By Jon Giles, MD

On June 2, 2010, the Advisory Committee for Reproductive Health Drugs of the U.S. Food and Drug Administration recommended approval of denosumab, which will be marketed under the trade-name Prolia, for the treatment of post-menopausal osteoporosis.  The drug was also recommended for the treatment of bone loss in men receiving hormone suppressive therapy for prostate […]

Dynamic Knee Alignment During Walking as a Risk Factor for Knee Osteoarthritis

May 27, 2010 By Jon Giles, MD

Knee alignment may be different during walking than when at rest.  Prior studies have identified varus thrust, a worsening of bow-leg alignment that occurs only during the weight bearing phase of walking, as a risk factor for developing knee osteoarthritis (OA).  Valgus thrust, or knock-knee alignment during walking, may also increase the risk of knee […]

Leflunomide and Pregnancy Outcomes Explored

May 24, 2010 By Jon Giles, MD

Leflunomide use during early pregnancy is associated with fetal malformations in animal studies and is classified as a pregnancy category X by the U.S. Food and Drug Administration.  However, little is known about pregnancy outcomes in humans exposed to leflunomide in early pregnancy, particularly in those who receive “wash-out” with cholestyramine (a drug sequestrant).   Here, […]

Targeting Interleukin-17 Studied in Rheumatoid Arthritis

April 29, 2010 By Jon Giles, MD

Recently, it has been recognized that a subset of T cells producing the cytokine IL-17 contribute to the pathogenesis of rheumatoid arthritis (RA).  Animal studies have suggested that blockade of IL-17 may reduce the inflammatory signs and symptoms of inflammatory arthritis and reduce bone erosion.  Here, Genovese et al report Phase I/II data for LY2439821, […]

Next Page »

Recent News

Exercise Tips for Arthritis Patients

Dr. Manno informs us on the background of the Johns Hopkins Rheumatology Exercise Center, as research was focused on muscle building

Risks and Benefits of Biologic Medications

Victoria Ruffing, RN, BC, Director of Patient Education at the Johns Hopkins Arthritis Center, shares the risks and benefits of biologic for

How to Manage Flares – Rheumatoid Arthritis

Through research, doctors have a clearer understanding of how flares can impact a patient on a personal and emotional level. Dr. Uzma Haque

Complementary & Alternative Medicines for Psoriatic Arthritis

There are many complementary & alternative medicines and practices that have been found to be beneficial in curbing arthritis pain,

I can’t be a runner because I have Rheumatoid Arthritis (RA), right?

Dr. Manno discusses running and Rheumatoid Arthritis. Is it an option for the RA patient?

News Categories

  • Ankylosing Spondylitis News
  • Fibromyalgia News
  • Gout News
  • Lupus News
  • Osteoarthritis News
  • Osteoporosis News
  • Psoriatic Arthritis News
  • Rheumatoid Arthritis News
U.S. News and World Report Rankings Badge

Connect With Us

  • Facebook
  • Twitter
  • YouTube
  • Johns Hopkins Rheumatology
  • Arthritis Center
  • Lupus Center
  • Lyme Disease Clinical Research Center
  • Myositis Center
  • Scleroderma Center
  • Sjogren’s Syndrome Center
  • Vasculitis Center

All information contained within the Johns Hopkins Arthritis Center website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.

Copyright Johns Hopkins Arthritis Center © 2019
Patient Privacy
Johns Hopkins Rheumatology